These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 22214308)
41. In vivo detection of monoaminergic degeneration in early Parkinson disease by (18)F-9-fluoropropyl-(+)-dihydrotetrabenzazine PET. Lin SC; Lin KJ; Hsiao IT; Hsieh CJ; Lin WY; Lu CS; Wey SP; Yen TC; Kung MP; Weng YH J Nucl Med; 2014 Jan; 55(1):73-9. PubMed ID: 24287322 [TBL] [Abstract][Full Text] [Related]
42. In vivo imaging of vesicular monoamine transporter 2 in pancreas using an (18)F epoxide derivative of tetrabenazine. Kung HF; Lieberman BP; Zhuang ZP; Oya S; Kung MP; Choi SR; Poessl K; Blankemeyer E; Hou C; Skovronsky D; Kilbourn M Nucl Med Biol; 2008 Nov; 35(8):825-37. PubMed ID: 19026944 [TBL] [Abstract][Full Text] [Related]
43. Synthesis and biological evaluation of 3-alkyl-dihydrotetrabenazine derivatives as vesicular monoamine transporter-2 (VMAT2) ligands. Zheng P; Lieberman BP; Choi SR; Plöessl K; Kung HF Bioorg Med Chem Lett; 2011 Jun; 21(11):3435-8. PubMed ID: 21531556 [TBL] [Abstract][Full Text] [Related]
44. Whole-body biodistribution and radiation dosimetry of 18F-FP-(+)-DTBZ (18F-AV-133): a novel vesicular monoamine transporter 2 imaging agent. Lin KJ; Weng YH; Wey SP; Hsiao IT; Lu CS; Skovronsky D; Chang HP; Kung MP; Yen TC J Nucl Med; 2010 Sep; 51(9):1480-5. PubMed ID: 20720042 [TBL] [Abstract][Full Text] [Related]
45. Development of a new radioligand, N-(5-fluoro-2-phenoxyphenyl)-N-(2-[18F]fluoroethyl-5-methoxybenzyl)acetamide, for pet imaging of peripheral benzodiazepine receptor in primate brain. Zhang MR; Maeda J; Ogawa M; Noguchi J; Ito T; Yoshida Y; Okauchi T; Obayashi S; Suhara T; Suzuki K J Med Chem; 2004 Apr; 47(9):2228-35. PubMed ID: 15084121 [TBL] [Abstract][Full Text] [Related]
46. A six-year longitudinal PET study of (+)-[ Kilbourn MR; Koeppe RA Nucl Med Biol; 2017 Dec; 55():34-37. PubMed ID: 29031997 [TBL] [Abstract][Full Text] [Related]
47. Influence of a low dose of amphetamine on vesicular monoamine transporter binding: a PET (+)[11C]DTBZ study in humans. Boileau I; Houle S; Rusjan PM; Furukawa Y; Wilkins D; Tong J; Selby P; Wilson AA; Kish SJ Synapse; 2010 Jun; 64(6):417-20. PubMed ID: 20169578 [TBL] [Abstract][Full Text] [Related]
48. 18F-labeled FECNT: a selective radioligand for PET imaging of brain dopamine transporters. Goodman MM; Kilts CD; Keil R; Shi B; Martarello L; Xing D; Votaw J; Ely TD; Lambert P; Owens MJ; Camp VM; Malveaux E; Hoffman JM Nucl Med Biol; 2000 Jan; 27(1):1-12. PubMed ID: 10755640 [TBL] [Abstract][Full Text] [Related]
49. A Purification Method of Dai Y; Sa R; Guan F; Wang Q; Li Y; Zhao H Front Med (Lausanne); 2021; 8():693632. PubMed ID: 34307421 [No Abstract] [Full Text] [Related]
50. Equilibrium versus compartmental analysis for assessment of the vesicular monoamine transporter using (+)-alpha-[11C]dihydrotetrabenazine (DTBZ) and positron emission tomography. Koeppe RA; Frey KA; Kume A; Albin R; Kilbourn MR; Kuhl DE J Cereb Blood Flow Metab; 1997 Sep; 17(9):919-31. PubMed ID: 9307605 [TBL] [Abstract][Full Text] [Related]
51. Rat pancreas uptake of [11C]dihydrotetrabenazine stereoisomers. Kilbourn MR Nucl Med Biol; 2010 Nov; 37(8):869-71. PubMed ID: 21055616 [TBL] [Abstract][Full Text] [Related]
52. Synthesis and evaluation of [18F]fluoroethyl SA4503 as a PET ligand for the sigma receptor. Elsinga PH; Kawamura K; Kobayashi T; Tsukada H; Senda M; Vaalburg W; Ishiwata K Synapse; 2002 Mar; 43(4):259-67. PubMed ID: 11835521 [TBL] [Abstract][Full Text] [Related]
53. Synthesis, radiolabeling, in vitro and in vivo evaluation of [18F]-FPECMO as a positron emission tomography radioligand for imaging the metabotropic glutamate receptor subtype 5. Lucatelli C; Honer M; Salazar JF; Ross TL; Schubiger PA; Ametamey SM Nucl Med Biol; 2009 Aug; 36(6):613-22. PubMed ID: 19647167 [TBL] [Abstract][Full Text] [Related]
54. Decreased striatal vesicular monoamine transporter 2 (VMAT2) expression in a type 1 diabetic rat model: A longitudinal study using micro-PET/CT. Jiang D; Kong Y; Ren S; Cai H; Zhang Z; Huang Z; Peng F; Hua F; Guan Y; Xie F Nucl Med Biol; 2020; 82-83():89-95. PubMed ID: 32120243 [TBL] [Abstract][Full Text] [Related]
55. In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's disease. Lee CS; Samii A; Sossi V; Ruth TJ; Schulzer M; Holden JE; Wudel J; Pal PK; de la Fuente-Fernandez R; Calne DB; Stoessl AJ Ann Neurol; 2000 Apr; 47(4):493-503. PubMed ID: 10762161 [TBL] [Abstract][Full Text] [Related]
56. In vivo evidence for low striatal vesicular monoamine transporter 2 (VMAT2) availability in cocaine abusers. Narendran R; Lopresti BJ; Martinez D; Mason NS; Himes M; May MA; Daley DC; Price JC; Mathis CA; Frankle WG Am J Psychiatry; 2012 Jan; 169(1):55-63. PubMed ID: 22193525 [TBL] [Abstract][Full Text] [Related]
57. Kinetic evaluation of [11C]dihydrotetrabenazine by dynamic PET: measurement of vesicular monoamine transporter. Koeppe RA; Frey KA; Vander Borght TM; Karlamangla A; Jewett DM; Lee LC; Kilbourn MR; Kuhl DE J Cereb Blood Flow Metab; 1996 Nov; 16(6):1288-99. PubMed ID: 8898703 [TBL] [Abstract][Full Text] [Related]
58. Monoaminergic PET imaging and histopathological correlation in unilateral and bilateral 6-hydroxydopamine lesioned rat models of Parkinson's disease: a longitudinal in-vivo study. Molinet-Dronda F; Gago B; Quiroga-Varela A; Juri C; Collantes M; Delgado M; Prieto E; Ecay M; Iglesias E; Marín C; Peñuelas I; Obeso JA Neurobiol Dis; 2015 May; 77():165-72. PubMed ID: 25681534 [TBL] [Abstract][Full Text] [Related]
59. Visualizing pancreatic beta-cell mass with [11C]DTBZ. Simpson NR; Souza F; Witkowski P; Maffei A; Raffo A; Herron A; Kilbourn M; Jurewicz A; Herold K; Liu E; Hardy MA; Van Heertum R; Harris PE Nucl Med Biol; 2006 Oct; 33(7):855-64. PubMed ID: 17045165 [TBL] [Abstract][Full Text] [Related]